PT-141 (Bremelanotide) is a synthetic peptide that selectively activates melanocortin receptors involved in various physiological processes, including sexual function. By binding to these receptors, PT-141 has been shown to modulate neuroendocrine pathways, leading to enhanced sexual arousal and desire. Its mechanism of action differs from traditional therapies, as it does not directly affect hormonal levels but influences central nervous system pathways that regulate sexual response. PT-141 is primarily researched in clinical and preclinical studies focused on sexual dysfunction in both men and women.

All research peptides are supplied in lyophilized (freeze-dried) powder form and are not reconstituted. This compound is intended strictly for research purposes and is available only to qualified professionals who acknowledge and adhere to the stated terms and conditions.